




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Mitral Regurgitation</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=a4c26654-d6e7-4dae-8f05-a936b77d628e</link>
        <description>Clinical Topic Feed: Mitral Regurgitation</description>
        <language>en</language>

        

                <item>
                    <title>Racial and Sex Disparities in M-TEER Outcomes | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/Racial-and-Sex-Disparities-in-M-TEER-Outcomes</link>                    <description>Black patients undergoing mitral transcatheter edge-to-edge repair (M-TEER) were more likely to present with more advanced disease, had lower procedural success and higher heart failure (HF) readmission rates vs. White patients, and female patients had lower procedural success rates vs. male patients...</description>
                    <pubdate>1780940640000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Editors&#39; Corner | The Ongoing Challenge of Tricuspid Regurgitation</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/01/Editors-Corner</link>                    <description>This month&#39;s cover story offers a practical, concise review of contemporary care for patients with tricuspid regurgitation (TR). It synthesizes key lessons from clinical trials that now guide decision-making for direct tricuspid valve interventions.</description>
                    <pubdate>1780316400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Maintaining Weight Loss With Tirzepatide</title>
<link>/Latest-in-Cardiology/Articles/2026/05/27/15/57/eagles-eye-view-27may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines recent research into maintaining weight loss with tirzepatide. He then offers insights into the new dyslipidemia guidelines, including addressing reproductive and hormone risk factors in cardiovascular risk assessment.</description>
                    <pubdate>1779898740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science From EuroPCR 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/JACC-Journals-Science-From-EuroPCR-2026</link>                    <description>Findings from four late-breaking clinical trials presented at EuroPCR 2026 in Paris, France, were simultaneously published in JACC: Cardiovascular Interventions. Together they lend new insights into residual tricuspid regurgitation (TR) after tricuspid valve transcatheter edge-to-edge repair (T-TEER), the safety of transfemoral (TF) transcatheter mitral valve replacement (TMVR), the novel BATMAN-TMVR technique, and the effect of implant depth on TAVR outcomes.</description>
                    <pubdate>1779371700000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PRAISE-MR: Sacubitril/Valsartan Improves Exercise Hemodynamics, Oxygen Consumption</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/PRAISE-MR</link>                    <description>In patients with atrial functional mitral regurgitation (AFMR) and heart failure with reduced ejection fraction (HFpEF), sacubitril/valsartan was associated with improvements in exercise hemodynamics and peak oxygen consumption (VO2), along with attenuation of an exercised-induced increase in AFMR...</description>
                    <pubdate>1779370200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Electronic Alerts For Managing AS, MR; More</title>
<link>/Latest-in-Cardiology/Articles/2026/05/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1777637400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Is Same-Day Discharge Safe After M-TEER?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/27/14/03/Is-Same-Day-Discharge-Safe-After-M-TEER</link>                    <description>Same-day discharge (SDD) following mitral transcatheter edge-to-edge repair (M-TEER) was found to be uncommon, but compared with next-day discharge (NDD) it was associated with a similar risk of 90-day readmission and lower costs for the index hospitalization, according to research presented April 25...</description>
                    <pubdate>1777386420000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALERT: Electronic Notifications Improve Management of AS, MR</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-145pm-alert-acc-2026</link>                    <description>Electronic clinician notification alerts were shown to be effective in improving the timely evaluation and treatment of patients with severe aortic stenosis (AS) or mitral regurgitation (MR), according to the ALERT trial presented during a Featured Clinical Research session...</description>
                    <pubdate>1774810200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Noninvasive Predictors of LA Compliance Post TMVT</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/09/18/56/Noninvasive-Predictors</link>                    <description>In patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...</description>
                    <pubdate>1770667920000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Elevated TMPG After Mitral TEER Associated With Worse Outcomes, Regardless of MR Severity</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/11/04/13/43/Elevated-TMPG-After-Mitral-TEER</link>                    <description>Elevated transmitral mean pressure gradient (TMPG) was associated with greater risk of all-cause death and heart failure (HF) hospitalization among patients with functional mitral regurgitation (MR) after mitral transcatheter edge-to-edge repair (TEER)...</description>
                    <pubdate>1762265520000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>